General
Preferred name
TOLFENAMIC ACID
Synonyms
GEA 6414 ()
Tolfedine ()
Clotam ()
Clotam Rapid ()
NSC-757873 ()
N-(3-chloro-o-tolyl)anthranilic ()
Acido tolfenamico ()
Acide tolfenamique ()
Tolfenamic Acid-d4 ()
P&D ID
PD001455
CAS
13710-19-5
1246820-82-5
Tags
available
drug
First approval
1976
Drug Status
approved
investigational
Max Phase
2.0
Drug indication
rheumatic disease
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory actions . (GtoPdb)
DESCRIPTION Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory and anti-cancer agent, selectively inhibits COX-2, with an IC50 of 13.49 ¦ÌM (3.53 ¦Ìg/mL) in LPS-treated (COX-2) canine DH82 monocyte/macrophage cells, but shows no effect on COX-1.
PRICE 29
DESCRIPTION Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory drug (NSAID) used to treat migraine symptoms. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
24
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
261.06
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
4.09
TPSA
49.33
Fraction CSP3
0.07
Chiral centers
0.0
Largest ring
6.0
QED
0.87
QED
0.87
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
COX
COX-2
MOA
cyclooxygenase inhibitor, prostanoid receptor antagonist
Indication
migraine headache
Pathway
Immunology/Inflammation
Neuroscience
Source data